These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6203801)

  • 21. Coupled secretion of gastric lipase and pepsin in man following pentagastrin stimulation.
    Szafran Z; Szafran H; Popiela T; Trompeter G
    Digestion; 1978; 18(5-6):310-8. PubMed ID: 35435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diversion of bile and pancreatic secretion in the rat and its effect on cysteamine-induced duodenal and peptic ulcer development under maximal acid secretion.
    Clémençon GH; Fehr HF; Finger J
    Scand J Gastroenterol Suppl; 1984; 92():112-5. PubMed ID: 6588494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [An experimental study of adrenalin-stimulated gastric acid secretion and gastrin secretion in rats of cysteamine-induced duodenal ulcer].
    Koga S; Kashiwagi H; Aoki T
    Nihon Shokakibyo Gakkai Zasshi; 1992 Mar; 89(3):580-7. PubMed ID: 1578802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of pirenzepine on basal gastric acid and pepsin secretion and on secretion stimulated with graded doses of pentagastrin in duodenal ulcer patients.
    Meneghelli UG; Troncon LE
    Braz J Med Biol Res; 1988; 21(4):781-9. PubMed ID: 3149202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decrease in alkaline secretion during duodenal ulceration induced by mepirizole in rats.
    Tabata K; Jacobson ED; Chen MH; Murphy RF; Joffe SN
    Gastroenterology; 1984 Aug; 87(2):396-401. PubMed ID: 6735082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for the involvement of dopamine agonists and antagonists in duodenal ulcer disease.
    Neumeyer JL; Szabo S
    Klin Wochenschr; 1986; 64 Suppl 7():123-7. PubMed ID: 3494157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of duodenal ulcerogens cysteamine, mepirizole, and MPTP on duodenal myoelectric activity in rats.
    Mangla JC; Pihan G; Brown HA; Rattan S; Szabo S
    Dig Dis Sci; 1989 Apr; 34(4):537-42. PubMed ID: 2784758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. From cysteamine to MPTP: structure-activity studies with duodenal ulcerogens.
    Szabo S; Cho CH
    Toxicol Pathol; 1988; 16(2):205-12. PubMed ID: 3055230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidermal growth factor inhibits cysteamine-induced duodenal ulcers.
    Kirkegaard P; Olsen PS; Poulsen SS; Nexø E
    Gastroenterology; 1983 Dec; 85(6):1277-83. PubMed ID: 6605273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of gastric distension on the secretion of acid and pepsin by patients with duodenal ulcer.
    Saunders JH; Wromsley KG
    Acta Hepatogastroenterol (Stuttg); 1977 Aug; 24(4):271-7. PubMed ID: 333847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of 5-acetylspiro[benzofuran-2(3H),1'-cyclopropan]-3-one, a new anti-ulcer agent, on experimental acute and chronic ulcers.
    Inatomi N; Hirata T; Inada I; Satoh H; Sino A; Maki Y
    Arzneimittelforschung; 1985; 35(10):1553-9. PubMed ID: 4074415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastric pepsin and acid secretion in patients with acute and healed duodenal ulcer.
    Achord JL
    Gastroenterology; 1981 Jul; 81(1):15-8. PubMed ID: 6786950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cysteamine-induced duodenal ulcer and the hepatoduodenal branch of the vagus nerve.
    Kato K; Watanabe T; Itoh M; Yoshida S; Hoshino N; Itoh K; Sugimura F; Iwasaki A; Matsuo Y; Sawai H
    Gastroenterol Jpn; 1990 Jun; 25(3):314-9. PubMed ID: 1972686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Examination of the potential antiulcer activity of the calcium antagonist propyl-methylenedioxyindene. III. Lack of effect on cysteamine-induced duodenal ulcers in rats.
    Wong WS; Rahwan RG; Stephens RL
    Pharmacology; 1990; 41(4):215-23. PubMed ID: 2080231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apparent and intrinsic sensitivity to pentagastrin of acid and pepsin secretion in peptic ulcer.
    Hirschowitz BI
    Gastroenterology; 1984 May; 86(5 Pt 1):843-51. PubMed ID: 6423436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cysteamine-induced duodenal ulcer is not site-specific: effect of local modulating factors.
    Adler RS; Nafradi J; Szabo S
    J Exp Pathol; 1985; 2(2):111-22. PubMed ID: 3842391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Indices of acid-base and pepsin-acid coefficients in the gastric contents of patients with duodenal ulcer].
    Movchan KN; Opanasenko NS
    Klin Khir (1962); 1992; (8):46-7. PubMed ID: 1287337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of trimipramine (Surmontil) on the gastric secretion of acid and pepsin in patients with duodenal ulceration.
    Mackay HP; Mitchell KG; Pickard WR; Hearns J; Crean GP
    J Int Med Res; 1984; 12(5):303-6. PubMed ID: 6437892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biphasic effect of duodenal ulcerogens on gastric emptying in the rat.
    Kline TJ; Pihan G; Szabo S
    Dig Dis Sci; 1988 Aug; 33(8):926-30. PubMed ID: 3260551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Duodenal ulcerogens cysteamine and propionitrile induce gastroduodenal motility alterations in the rat.
    Pihan G; Kline TJ; Hollenberg NK; Szabo S
    Gastroenterology; 1985 Apr; 88(4):989-97. PubMed ID: 3972237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.